NCT06872424

Brief Summary

The aim of this study was to evaluate the effect of psychosocial skills-oriented group psychoeducation on functional recovery, treatment adherence and mental well-being in patients with schizophrenia. This research will be conducted in Giresun Community Mental Health Center. The study was planned as a randomized controlled pretest-posttest design. In addition to the Sociodemographic Information Form prepared by the researchers, the Functional Recovery Scale in Schizophrenia, the Modified Morisky Treatment Adherence Scale and the Warwick-Edinburgh Mental Well-Being Scale will be used to collect the data. The sample size was calculated as 34 people (experimental group= 17, control group= 17). Forms and scales will be applied to the experimental and control groups before psychoeducation and scales will be applied again to both groups after psychoeducation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 12, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

April 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

March 12, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

February 27, 2025

Last Update Submit

March 10, 2025

Conditions

Keywords

SchizophreniaPsychoeducationFunctional recoveryTreatment adherenceMental well-being

Outcome Measures

Primary Outcomes (3)

  • Functional Recovery Scale in Schizophrenia

    Functional Recovery Scale: The scale is 5-point Likert-type and consists of 19 items. The maximum score that can be obtained from the scale is 95 and the minimum score is 19. Patients who score below 58 points are considered to have a low level of Functional Recovery, patients who score between 59-65 points are considered to have a moderate level of Functional Recovery, and patients who score 66 points and above are considered to have a high level.

    1 day

  • Morisky Treatment Adherence Scale

    Morisky Treatment Adherence Scale: The scale consists of 4 closed-ended questions with two options (yes/no). Medication adherence is assessed as high if "no" is answered to all questions (4 points), moderate if "yes" is answered to one or two questions (2-3 points), and low if "yes" is answered to three or four questions (0-1 pn).

    1 day

  • Warwick-Edinburgh Mental Well-Being Scale

    Warwick-Edinburgh Mental Well-Being Scale: The scale consists of 14 items and each question is scored between 1-5. The total score range is 14-70. A higher score indicates a higher level of mental well-being.

    1 day

Study Arms (1)

Effect of psychoeducation on schizophrenia patients

EXPERIMENTAL

Experimental and control group

Behavioral: psychosocial skills-oriented group psychoeducation

Interventions

A 5-session Psychosocial Skills Focused Group Psychoeducation will be implemented, each session lasting approximately 60-90 minutes. In order to make the training more active and effective, the experimental group will be divided into small groups and divided into 3 groups and each group will be given 5 sessions of Psychosocial Skills Focused Group Psychoeducation once a week.

Effect of psychoeducation on schizophrenia patients

Eligibility Criteria

Age18 Weeks+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Having a diagnosis of schizophrenia according to DSM-5 diagnostic criteria
  • To have continuity in the Community Mental Health Center
  • Being in remission (period without psychotic exacerbation) as a result of the evaluation of the outpatient clinic doctor,
  • To be mentally capable of understanding the questions posed
  • To have the cognitive competence to understand the training provided
  • Not having any visual or auditory disability
  • Graduating from at least primary school

You may not qualify if:

  • Refusing to participate in the study
  • Being under 18 years of age
  • Being illiterate in Turkish
  • Having Mental Retardation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SchizophreniaTreatment Adherence and CompliancePsychological Well-Being

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersHealth BehaviorBehaviorPersonal Satisfaction

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Pre-test post-test control group study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Research Assistant

Study Record Dates

First Submitted

February 27, 2025

First Posted

March 12, 2025

Study Start

April 15, 2025

Primary Completion

July 15, 2025

Study Completion

August 15, 2025

Last Updated

March 12, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share